Inventor · disambiguated record
Orville G. Kolterman
Also filed as: KOLTERMAN ORVILLE · KOLTERMAN ORVILLE G
13 granted patents·15 pending applications·536 citations·filing 1994–2023
94Inventor score
Files withAMYLIN PHARMACEUTICALS INC13PENDULUM THERAPEUTICS INC6AMYLIN PHARMACEUTICALS LLC3DUFT BRADFORD J1KOLTERMAN ORVILLE G1
Top patents by PatentIndex Score
28 records- 0197US6902744B1Exendin agonist formulations and methods of administration thereofAMYLIN PHARMACEUTICALS INC·Filed 2000·Granted Jun 7, 2005·180 cites·42 claims
- 0295US7399489B2Exendin analog formulationsAMYLIN PHARMACEUTICALS INC·Filed 2005·Granted Jul 15, 2008·40 cites·36 claims
- 0393US6114304AMethods for regulating gastrointestinal motilityAMYLIN PHARMACEUTICALS INC·Filed 1994·Granted Sep 5, 2000·103 cites·35 claims
- 0492US11583558B2Methods and compositions for treatment of microbiome-associated disordersPENDULUM THERAPEUTICS INC·Filed 2020·Granted Feb 21, 2023·3 cites·15 claims
- 0591US7906146B2Lyophilized formulations of exendins and exendin agonist analogsAMYLIN PHARMACEUTICALS INC·Filed 2009·Granted Mar 15, 2011·14 cites·20 claims
- 0689US6417164B1Treatment of type II diabetes mellitus with amylin agonistsAMYLIN PHARMACEUTICALS INC·Filed 2000·Granted Jul 9, 2002·37 cites·18 claims
- 0785US6136784AAmylin agonist pharmaceutical compositions containing insulinAMYLIN PHARMACEUTICALS INC·Filed 1998·Granted Oct 24, 2000·81 cites·8 claims
- 0879US5795861AMethods for regulating gastrointestinal motilityAMYLIN PHARMACEUTICALS INC·Filed 1995·Granted Aug 18, 1998·33 cites·6 claims
- 0978US12233095B2Methods and compositions for treatment of microbiome associated disordersPENDULUM THERAPEUTICS INC·Filed 2023·Granted Feb 25, 2025·0 cites·20 claims
- 1074US6143718ATreatment of Type II diabetes mellutis with amylin agonistsAMYLIN PHARMACEUTICALS INC·Filed 1995·Granted Nov 7, 2000·32 cites·21 claims
- 1173US2008249018A1Exendin Analog FormulationsAMYLIN PHARMACEUTICALS INC·Filed 2008·Application pending·0 cites
- 1272US6608029B1Methods for regulating gastrointestinal motilityAMYLIN PHARMACEUTICALS INC·Filed 2000·Granted Aug 19, 2003·6 cites·22 claims
- 1370US7407934B2Methods for regulating postprandial blood glucoseAMYLIN PHARMACEUTICALS INC·Filed 2003·Granted Aug 5, 2008·4 cites·29 claims
- 1464US2015080308A1Formulations and Uses of Exendins and Exendin Agonist AnalogsAMYLIN PHARMACEUTICALS LLC·Filed 2014·Application pending·0 cites
- 1561US2011281798A1Methods for Lowering Plasma Glucagon with Exendins and Exendin Agonist AnalogsKOLTERMAN ORVILLE G·Filed 2011·Application pending·0 cites
- 1659US2013165379A1Formulations of Exendins and Exendin Agonist AnalogsAMYLIN PHARMACEUTICALS LLC·Filed 2012·Application pending·0 cites
- 1756US2012196799A1Amylin Family Peptides and Methods for Making and Using ThemDUFT BRADFORD J·Filed 2012·Application pending·0 cites
- 1855US2024277781A1Compositions Comprising Microbes and Methods of Use and Making ThereofPENDULUM THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1951US2020121738A1Methods and compositions relating to isolated and purified microbesPENDULUM THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 2050US2006183677A1Novel exendin agonist formulations and methods of administration thereofYOUNG ANDREW A·Filed 2003·Application pending·0 cites
- 2150US2021213078A1Microbial compositions and methods of usePENDULUM THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2249US2022211780A1Methods And Compositions For Treating Liver DisordersPENDULUM THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2348US2003087820A1Novel exendin agonist formulations and methods of administration thereofFiled 2002·Application pending·0 cites
- 2445US2003130177A1Use of amylin agonists to modulate triglyceridesFiled 2003·Application pending·0 cites
- 2539US7910548B2Methods for treating obesityAMYLIN PHARMACEUTICALS INC·Filed 1997·Granted Mar 22, 2011·3 cites·10 claims
- 2639US2003036504A1Use of exendins and agonists thereof for modulation of triglyceride levels and treatment of dyslipidemiaAMYLIN PHARMACEUTICALS INC·Filed 2001·Application pending·0 cites
- 2734US2015174209A1Insulin-pramlintide compositions and methods for making and using themAMYLIN PHARMACEUTICALS LLC·Filed 2013·Application pending·0 cites
- 2830US2004022807A1Methods for treating obesityFiled 1998·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Orville G. Kolterman files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →